Cost-conscious consumers who want to stretch their dollar further will have a chance to make both a great wine purchase and a charitable donation during the entire month of September, when Viña Montes kicks off their “Angels in Action” fundraiser in support of Cystic Fibrosis Foundation (CFF). Viña Montes, the world-renowned Chilean winery helmed by winemaker Aurelio Montes, has partnered with its distributors in key markets across the United States to donate 10 percent of proceeds from every bottle sold during the month of September (applies only to participating markets).
Aurelio Montes hosted a ticketed tasting event in Los Angeles on June 7th to announce “Angels in Action” and commence its fundraising efforts; all proceeds from the event were donated to CFF. See clips from the event and learn more about “Angels in Action” by viewing this video.
The September sales fundraiser is a joint effort with our distributors in California, Maryland, Washington D.C., New Jersey, Pennsylvania, Delaware and Florida; donations will be calculated from sales in these states only. Our distributor partners include the following:
Titan Wine and Spirits
R & R Marketing
Capital Wine & Spirits
Premier Beverage Group
About Viña Montes:
Founded in 1988, Viña Montes is the brainchild of Aurelio Montes and Douglas Murray, both veterans of the wine industry. Along with partners Alfredo Vidaurre and Pedro Grand, they created Viña Montes with the goal of elevating the quality and reputation of Chilean wines - both in Chile and around the world. In the quarter century since, Viña Montes has played a pivotal role in enhancing awareness, affinity, and acclaim for Chilean wines in more than 100 countries worldwide. In essence, Viña Montes has become the benchmark for premium Chilean wines.
About Cystic Fibrosis Foundation:
The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis and funds more CF research than any other organization. The Foundation's pioneering and successful approach to the development of new drugs for cystic fibrosis has been featured in some of the country's most prestigious and influential publications.